Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
1.250
-0.020 (-1.57%)
At close: Apr 1, 2025, 4:00 PM
1.270
+0.020 (1.57%)
After-hours: Apr 1, 2025, 4:02 PM EDT
Evogene Market Cap
Evogene has a market cap or net worth of $8.34 million as of April 1, 2025. Its market cap has decreased by -81.57% in one year.
Market Cap
8.34M
Enterprise Value
11.75M
1-Year Change
-81.57%
Ranking
Category
Stock Price
$1.25
Market Cap Chart
Since October 15, 2007, Evogene's market cap has decreased from $28.02M to $8.34M, a decrease of -70.22%. That is a compound annual growth rate of -6.70%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |